Author

James Hoffman

University of Miami

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Plant Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cell-cell communication· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1

Frequent Co-Authors

Abhishek PandeyiD· 1 shared Adriana E. Larrea-SarmientoiD· 1 shared Akhilesh PandeyiD· 1 shared Alejandro Olmedo-VelardeiD· 1 shared Aneta MikulášováiD· 1 shared Ariana Makar· 1 shared Attaya SuvannasankhaiD· 1 shared Benjamin T. DiamondiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Abhishek PandeyORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Genomic characterization of patient derived xenograft models of multiple myeloma reveals selection of multiple pre-existing high risk clones

Nathan J. Becker, Enze Liu, Riya Sharma, Parvathi Sudha, Sara Ortega‐Bertran, Oumaima Jaouadi, Sreejeta Mondal, Nelia Luviano Aparicio, Maurizio Affer, Kiran Kumar Mangalaparthi, Akhilesh Pandey, Marios Papadimitriou, Benjamin T. Diamond, David Glen Coffey, Abhishek Pandey, , Brian A. Walker

This study uses SCID-rab PDX models to analyze genomic and transcriptomic features of multiple myeloma, revealing selection of pre-existing high-risk clones.

bioRxiv · Oct 16, 2026 · PreprintCancer Biology

The "Grove-First" Framework: Starting in the Grove to Find Therapies for Huanglongbing

Michelle Lynn Heck, Nicholas R. Larson, Guilherme Locatelli, Ellen F. Cochrane, Samuel T. Coradetti, Lukas M. Hallman, Lynn M. Johnson, W. Cody Estes, Ariana Makar, Nursena Demirden, Marco Pitino, Robert G. Shatters, Robert C. Adair, Frank Giles, John-Paul Fox, , Randall P. Niedz

The paper introduces the Grove-First framework to rapidly screen HLB therapies in citrus groves, identifying candidates with effects comparable to or better than oxytetracycline.

bioRxiv · May 22, 2025 · PreprintPlant Biology